Cardio Diagnostics Holdings Inc (CDIO) — Capital Reinvestment Ratio

Latest as of December 2020: 1.16x

Cardio Diagnostics Holdings Inc (CDIO) has a Capital Reinvestment Ratio of 1.16x as of December 2020, meaning it reinvests 1% of its operating cash flow ($25.86K) in capital expenditures ($29.91K). Check Cardio Diagnostics Holdings Inc tangible equity quality to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.16x
Capex / Operating Cash Flow

Operating Cash Flow

$25.86K
USD

Capital Expenditures

$29.91K
USD

Data as of

Dec 2020
Most recent filing

Cardio Diagnostics Holdings Inc Capital Reinvestment Ratio (2020–2020)

This chart tracks Cardio Diagnostics Holdings Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see CDIO cash generation efficiency.

Annual Capital Reinvestment Ratio for Cardio Diagnostics Holdings Inc (2020–2020)

Year-by-year Capital Reinvestment Ratio for Cardio Diagnostics Holdings Inc from 2020 to 2020. See cash generation quality of Cardio Diagnostics Holdings Inc to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2020 1.16x $25.86K $29.91K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow